TC
DPLO

Telemus Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Telemus Capital’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,825
Closed -$68K – 419
2019
Q3 		$68K Hold
13,825
– – 0.01% 387
2019
Q2 		$71K Hold
13,825
– – 0.01% 366
2019
Q1 		$80K Buy
13,825
+1,550
+13% +$16K 0.01% 419
2018
Q4 		$165K Sell
12,275
-500
-4% -$8.43K 0.01% 403
2018
Q3 		$248K Hold
12,775
– – 0.02% 393
2018
Q2 		$327K Sell
12,775
-500
-4% -$11.7K 0.03% 352
2018
Q1 		$267K Buy
+13,275
New +$310K 0.02% 365
2016
Q3 		– Sell
-6,425
Closed -$225K – 359
2016
Q2 		$225K Buy
+6,425
New +$202K 0.03% 311

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Telemus Capital's DPLO Position: Q4 2019 in Review

Telemus Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 13,825 shares — an estimated $68K sold.

Telemus Capital first reported a position in DPLO in Q2 2016 and held it in 8 quarters. The position peaked at $327K in Q2 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Telemus Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Telemus Capital sold 13,825 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $68K.
  • Telemus Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 8 quarters.
  • Telemus Capital's DIPLOMAT PHARMACY, INC. position peaked at $327K in Q2 2018.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Telemus Capital's 13F filing for Q4 2019, filed 24 Jan 2020.